Skip to main content
Caplight Logo









TJM

TJM

Private
Wilmington, DelawareHealthcare & Life Scienceshttps://tjmlabs.com/

Last Round

Series B

Jul 2, 2026

Est. Valuation

$375M

Total Funding Raised

$75M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

TJM Labs is a healthcare technology company that provides an AI-powered platform to automate pharmacy operations, including prescription intake, data processing, and patient communication.

Sector

Healthcare & Life Sciences

Verticals

Workflow Automation, Medical AI, Vertical SaaS, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

pharmacy automationAI agentsrobotic process automationRPApharmacy workflow automationpharmacy back office automationprescription data entryrefill managementprior authorization supporthealthcare automationspecialty pharmacy softwaredigital workerlong-term care pharmacyLTC pharmacymedical AIpatient engagementVoiceAI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TJM Comparables

Compare TJM with similar companies based on industry and business-model similarity.

TJM comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Asepha
72%
Innovaccer
70%
Sully.ai
66%

TJM Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 2, 2026

TJM Investors

Notable investors and investment history

TJM investors
InvestorRounds
Arthur VenturesSeries B
Updata PartnersSeries B
ElephantSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2026

    $75M round led by Elephant

TJM Filings

Explore SEC and related filing metadata, where available.

TJM filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TJM's valuation, stock price, and market status.

Is TJM a public or private company?

TJM is a private company.

What is the current stock price of TJM?

TJM is a private company with no public stock price. No recent secondary market data is available.

How much is TJM worth (valuation)?

TJM's valuation is estimated at $375.0M based on funding round data.

Can I buy TJM stock?

TJM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TJM's last funding round?

TJM's most recent funding round was Series B on July 2, 2026.

Who are the main investors in TJM?

Key investors in TJM include Elephant.

Will TJM IPO soon?

No public IPO plans have been announced for TJM.

How can I track TJM secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TJM's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWilmington, Delaware
Year Founded2024
Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?